StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)

Close on Nov 17, 2026Market cap $2.38BP/E –Yield –

Neogen EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Neogen's EV/EBITDA was 35.9× on Nov 11, 2026, against 19.3× a year earlier. Over the last 5 years it ranged from 13.7× to 78.2×, with a median of 39.5×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202635.9×+14.6
2024Dec 31, 202421.3×−9.6
2023Dec 29, 202330.9×+11.4
2022Dec 30, 202219.4×−25.8
2021Dec 31, 202145.2×+2.0
2020Dec 31, 202043.2×+6.7
2019Dec 31, 201936.5×+5.3
2018Dec 31, 201831.3×−5.2
2017Dec 29, 201736.5×−9.6
2016Dec 30, 201646.1×+4.7
2015Dec 31, 201541.4×−2.2
2014Dec 31, 201443.5×+1.4
2013Dec 31, 201342.1×+9.0
2012Dec 31, 201233.2×+11.1
2011Dec 30, 201122.0×−17.6
2010Dec 31, 201039.6×–

More Neogen figures

See a number that looks wrong?